ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2026

Developing a Guided Joint Self-Exam for Rheumatoid Arthritis Patients to Use in Telehealth-Delivered Care

Kelly Gavigan1, David Curtis2, Jeffrey Curtis3, W. Benjamin Nowell4, Danielle Ali5, Neelkamal Soares6, John Cush7, Rebecca Grainger8, Manas Jinka9, Sandeep Sodhi10, Natalie Fortune9 and Swamy Venuturupalli9, 1Global Healthy Living Foundation, Upper Nyack, NY, 2Global Healthy Living Foundation, San Francisco, CA, 3University of Alabama at Birmingham, Birmingham, AL, 4Global Healthy Living Foundation, Nyack, NY, 5Global Healthy Living Foundation, Upper Nayack, NY, 6Western Mich Univ Homer Stryker MD Sch of Medicine, Kalamazoo, MI, 7University of Texas Southwestern Medical School, Dallas, TX, 8University of Otago, Wellington, New Zealand, 9Attune Health, Beverly Hills, CA, 10Illumination Health, Hoover, AL

Meeting: ACR Convergence 2023

Keywords: education, patient, Patient reported outcomes, physical examination, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2019–2038) Patient Outcomes, Preferences, & Attitudes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Telehealth services and, increasingly, remote therapeutic monitoring, can be used to enable the continuum of clinical care in out-of-office settings. This remotely provided care can increase personalization of healthcare by using patient-relevant data, but lack of opportunity for in-person examination may remain a barrier. Our objective was to develop and pilot a smartphone application (app)-based program to teach patients to perform guided self-examination to measure the disease activity of their rheumatoid arthritis (RA), to facilitate remote care.

Methods: An in-app tool to instruct patients with RA to conduct a self-guided 28 tender and swollen joint count (28-TJC, 28-SJC) was developed for the ArthritisPower research registry app based on previously developed videos1. An instructional script of on-screen messaging and animations was iteratively refined by the study team of physicians, researchers, patients, and patient advocates. A storyboard of the final script was user tested with ArthritisPower members living with RA. The tool was then piloted in the ArthritisPower app by RA patients in a community rheumatology practice to gain feedback on the user interface and user experience. Participation in the pilot consisted of registering for ArthritisPower, completing six physical and social health patient reported outcomes (PROs) (PROMIS measures for Pain Interference, Physical Function, Fatigue, and Satisfaction with Participation in Discretionary Activities; RADAI-5; and OMERACT RA Flare), and completing the guided, self-conducted 28-TJC, 28-SJC. The in-app assessment was compared to in-person assessment by a rheumatologist within 6 days of a scheduled office visit.

Results: Five RA patients participated in the pilot testing. The mean (SD) time to completion for the PROs and joint self-assessment tool was 18.3 (3.5) minutes, with the PROs taking 5.4 (0.9) minutes on average and the joint self-assessment taking 12.9 (3.5) minutes on average to complete. Based on this pilot, edits were made to the tool. These included simplifying the language in the registration process, clarifying what was required to successfully complete participation and the expected time commitment, clarifying concepts of tender and swollen joints, adding inspirational progress messaging, and refining the instructional tool. Example screens from the in-app module can be found in Figure 1.

Conclusion: Piloting in real-world settings highlighted areas for change that are hoped to increase successful participation, such as simplifying language, clarifying requirements, and adding motivational messaging. The refined tool is currently being deployed in a larger study to evaluate the accuracy and utility of patient-conducted TJC and SJC for guiding RA management decisions. 1Grainger, et al. ACR Open Rheum. 2020;2(12):705-709.

Supporting image 1

FIGURE 1. Example Screens from the In-App Joint Count Tool


Disclosures: K. Gavigan: Global Healthy Living Foundation, 3; D. Curtis: Global Healthy Living Foundation, 3; J. Curtis: AbbVie, 2, 5, Amgen, 2, 5, Bristol-Myers Squibb, 2, 5, CorEvitas, 2, 5, Eli Lilly and Company, 2, 5, Janssen, 2, 5, Myriad, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, 5, UCB, 2, 5; W. Nowell: AbbVie/Abbott, 2, 5, Amgen, 5, Janssen, 2, 5, Scipher Medicine, 5; D. Ali: Global Healthy Living Foundation, 3; N. Soares: None; J. Cush: None; R. Grainger: AbbVie, 2, 6, Cornerstones, 6, Janssen, 6, Novartis, 2, Pfizer, 6; M. Jinka: None; S. Sodhi: None; N. Fortune: None; S. Venuturupalli: None.

To cite this abstract in AMA style:

Gavigan K, Curtis D, Curtis J, Nowell W, Ali D, Soares N, Cush J, Grainger R, Jinka M, Sodhi S, Fortune N, Venuturupalli S. Developing a Guided Joint Self-Exam for Rheumatoid Arthritis Patients to Use in Telehealth-Delivered Care [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/developing-a-guided-joint-self-exam-for-rheumatoid-arthritis-patients-to-use-in-telehealth-delivered-care/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/developing-a-guided-joint-self-exam-for-rheumatoid-arthritis-patients-to-use-in-telehealth-delivered-care/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology